跳至主要内容
临床试验/NCT07796165
NCT07796165尚未招募不适用

SNIP 2 Case Series

Europa Life Sciences Limited1 个研究点 分布在 1 个国家目标入组 6 人开始时间: 2026年10月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
6
试验地点
1
主要终点
Clinician Device Experience

研究概览

简要总结

Case series of infants with anterior ankyloglossia being treated by the Sublingual Neonatal Incision Platform device

详细描述

A study assessing the feasibility of a novel device designed specifically to treat infant tongue-tie.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Device Feasibility
盲法
None

入排标准

年龄范围
1 Week 至 12 Weeks(Child)
性别
All
接受健康志愿者

入选标准

  • Ankyloglossia requiring intervention

排除标准

  • Concomitant morphological variation in the oral cavity which could compromise frenotomy
  • Blood dyscrasia
  • Immunocompromise

研究组 & 干预措施

Non-treatment

No Intervention

Patient identified as not requiring frenotomy

Infant with ankyloglossia requiring intervention

Experimental

Patient is treated using the novel device

干预措施: Frenectomy of anterior ankylogossia using the novel device (Device)

结局指标

主要结局

Clinician Device Experience

时间窗: Immediately post-op

The physician will be asked to rate following attributes of the use of the tool, in Likert scale of 1-5; Whether the device felt intuitive, whether they felt more confident using this device, whether they would use this device again for a similar release?

次要结局

  • Operator-perceived infant discomfort(Immediately post-op)

研究者

发起方
Europa Life Sciences Limited
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验